clenbuterol has been researched along with xamoterol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, M; Hacker, S; Poat, J; Stahl, SM | 1 |
| Bross, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pahl, HL; Pannen, BHJ; Schmidt, R | 1 |
2 other study(ies) available for clenbuterol and xamoterol
| Article | Year |
|---|---|
Independent regulation of beta 1- and beta 2-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Cerebral Cortex; Clenbuterol; Desipramine; In Vitro Techniques; Iodine Radioisotopes; Male; Pindolol; Prenalterol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Xamoterol | 1987 |
Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Anti-Inflammatory Agents; CD3 Complex; Cell Nucleus; Clenbuterol; DNA; Dobutamine; Electrophoretic Mobility Shift Assay; Humans; Jurkat Cells; NF-kappa B; Receptors, Adrenergic, alpha; T-Lymphocytes; Tetradecanoylphorbol Acetate; Xamoterol | 2004 |